Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

A.H. Eijkelboom, L. de Munck, M.B.I. Lobbes, C.H. van Gils, J. Wesseling, P.J. Westenend, C.G. Paez, R.M. Pijnappel, H.M. Verkooijen, M.J.M. Broeders, S. Siesling*, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Web of Science)
Original languageEnglish
Article number106602
Number of pages10
JournalPreventive Medicine
Volume151
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • COVID-19
  • Breast cancer incidence
  • Breast cancer screening
  • cT-stage
  • Clinical tumor stage

Cite this